The ADP-deleted vectors demonstrated impressive oncolysis upon extremely low titers of infection at 1 and 0.1 pfu/cell in all tested breast cancer subtypes, including HER2+, triple-negative, and estrogen receptor-positive (ER+) cells. Here, ERBB2 is linked to breast cancer.